| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/26/2000 | EP1021536A2 Mammalian genes involved in viral infection and tumor suppression |
| 07/26/2000 | EP1021533A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 07/26/2000 | EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
| 07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 07/26/2000 | CN1261404A Lentivirus-Based gene transfer vectors. |
| 07/26/2000 | CN1261403A Surface exposed proteins from chlamydia pneumoniae |
| 07/26/2000 | CN1261373A Compositions and methods for activating genes of interest |
| 07/25/2000 | US6093811 Oligonucleotide modulation of cell adhesion |
| 07/25/2000 | US6093809 Nucleotide sequence; anticarcinogenic and antiaging agents; diagnostic applications; evolutionary (e.g., phylogenetic) investigations |
| 07/25/2000 | US6093701 Method for covalent attachment of compounds to genes |
| 07/25/2000 | US6093700 Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF |
| 07/25/2000 | US6093699 Method for gene therapy involving suppression of an immune response |
| 07/25/2000 | US6093567 Gene therapy for cystic fibrosis |
| 07/25/2000 | US6093557 Electrospraying apparatus and method for introducing material into cells |
| 07/25/2000 | US6093555 Amido and peptido modified enzymatic nucleic acid molecules |
| 07/25/2000 | US6093531 Generation of hematopoietic cells from multipotent neural stem cells |
| 07/25/2000 | US6093393 Methods for preparing and using clonogenic fibroblasts and transfected clonogenic fibroblasts |
| 07/25/2000 | US6093392 Comprising a recombinant adeno-associated viral vector |
| 07/25/2000 | US6093390 Methods for promoting functional regeneration of mammalian muscle by administering leukaemia inhibitor factor |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/20/2000 | WO2000042208A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 07/20/2000 | WO2000042202A1 A method for introducing substances into cells, and use of said method |
| 07/20/2000 | WO2000042201A2 Human peptidases |
| 07/20/2000 | WO2000042192A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042174A1 Double nuclear transfer method and results thereof |
| 07/20/2000 | WO2000042173A1 Catalytic molecules |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042165A2 Bone marrow-specific protein |
| 07/20/2000 | WO2000041731A1 Reverse gene therapy |
| 07/20/2000 | WO2000041717A2 Chorionic gonadotropin dna vaccines and methods |
| 07/20/2000 | WO2000041647A1 Sustained delivery of polyionic bioactive agents |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041516A2 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | WO2000041508A2 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines |
| 07/20/2000 | WO2000041497A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
| 07/20/2000 | WO2000028031A8 Mitogenic regulators |
| 07/20/2000 | WO2000024885A3 p53 MORPHOLINO-BASED ANTISENSE |
| 07/20/2000 | WO2000020582A3 Gene replacement therapy for muscular dystrophy |
| 07/20/2000 | WO2000020572A3 Tissue binding peptides, identification, production and utilization thereof |
| 07/20/2000 | WO2000020041A3 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 07/20/2000 | WO2000016800A3 Methods of treating chronic pain |
| 07/20/2000 | WO2000015795A3 Genes from human chromosome 11p15.5 |
| 07/20/2000 | WO2000015246A3 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 07/20/2000 | WO2000002950A9 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
| 07/20/2000 | WO2000002897A9 Delta cleavage products and methods based thereon |
| 07/20/2000 | WO1999063094A9 Nucleotide and protein sequences of gpr1 and methods based thereon |
| 07/20/2000 | WO1999054353A3 Human nucleic acid sequences of normal uterus tissue |
| 07/20/2000 | DE19900284A1 Method for introducing DNA into eukaryotic cells, useful in gene therapy, particularly of lymphoma, by incubation with adenovirus |
| 07/20/2000 | DE19855013A1 Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element Androgen and progesterone receptor binding hormone response element |
| 07/20/2000 | CA2360549A1 Double nuclear transfer method and results thereof |
| 07/20/2000 | CA2360464A1 Human peptidases |
| 07/20/2000 | CA2360387A1 Catalytic molecules |
| 07/20/2000 | CA2359795A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 07/20/2000 | CA2359486A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359392A1 Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
| 07/20/2000 | CA2359349A1 A method for introducing substances into cells, and use of said method |
| 07/20/2000 | CA2359132A1 Bone marrow-specific protein |
| 07/20/2000 | CA2358748A1 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | CA2357726A1 Chorionic gonadotropin dna vaccines and methods |
| 07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/19/2000 | EP1020529A2 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 07/19/2000 | EP1020520A1 Prevention of immune related removal of cells from the mammalian body, mutant PML molecules useful therefor |
| 07/19/2000 | EP1019518A1 Self-deleting vectors for cancer therapy |
| 07/19/2000 | EP1019515A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 07/19/2000 | EP1019506A1 101 human secreted proteins |
| 07/19/2000 | EP1019505A1 Human hox c10 and polynucleotides encoding |
| 07/19/2000 | EP1019500A2 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/19/2000 | EP1019499A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/19/2000 | EP1019493A1 Generation of hematopoietic cells from multipotent neural stem cells |
| 07/19/2000 | EP1019490A2 Methods for modulating hematopoiesis and vascular growth |
| 07/19/2000 | EP1019435A1 Amplification of response from expressed recombinant protein |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019431A1 Novel rnase p |
| 07/19/2000 | EP1019429A1 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 07/19/2000 | EP1019428A2 Inverted chimeric and hybrid oligonucleotides |
| 07/19/2000 | EP1019417A1 Phospholipid analogue compounds |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019082A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/19/2000 | EP1019078A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis |
| 07/19/2000 | EP1019065A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | CN1260835A Truncated vegf-related proteins |
| 07/19/2000 | CN1260721A Use of cartilage oligeomeric matrix protein for treatment of rheumatoid |
| 07/19/2000 | CN1260396A Human tree protuberant cytoma immuno-therapu preparation for oriented proliveration and expression interleukin 12 and its preparation method |
| 07/18/2000 | US6090790 Gene delivery by microneedle injection |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090778 Neurturin and related growth factors |
| 07/18/2000 | US6090618 DNA constructs and viral vectors comprising a smooth muscle promoter |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090608 Viral expression vector coding heterologous proteins; for the treatment of thalassemia, hemopoietic defects, bacterial and viral infctions, atherosclerosis, autoimmune diseases or allergies; anticarcinogenic agents |
| 07/18/2000 | US6090600 Valyl tRNA synthetase from Staphylococcus aureus |
| 07/18/2000 | US6090583 Expression system in compatible host cell of a polynucleotide which produces a metalloprotease; diagnosis and treatment of asthma, disorders of leukotriene metabolism; anticarcinogenic agents; antiinflammatory/antidiabetic/antiarthritic agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090575 Nucleotide and amino acid sequences; diagnosis and therapy of asthma, parkinson's disease, acute heart failure, urinary retention, osteoporosis, angina pectoris, myocardial infarction, allergies; antiulcer agents |
| 07/18/2000 | US6090564 Amino acid sequence of human small nuclear ribonucleoprotein protein; for diagnosis, prevention and treatment of systemic lupus erythematosus |